[评论] 被忽视的巨细胞病毒(CMV)在HIV感染婴儿肺炎中的作用
摘要
数十年来,HIV感染婴儿的重症肺炎一直被视为一场与时间的赛跑。临床医生迅速启动广谱抗生素治疗,对疑似耶氏肺孢子菌肺炎进行经验性治疗,提供支持性护理,并越来越多地根据WHO建议在高负担环境中考虑经验性结核治疗。1 然而,尽管采取了这些干预措施,死亡率仍然高得令人无法接受。2 Cinta Moraleda及其同事开展的EMPIRICAL试验挑战了另一个长期存在的假设;也许一种重要的病原体一直就隐藏在显而易见之处。
English
For decades, severe pneumonia in infants with HIV has been treated as a race against time. Clinicians rapidly initiate broad-spectrum antibiotics, empirically treat suspected Pneumocystis jirovecii pneumonia, provide supportive care, and increasingly consider empirical tuberculosis treatment in high-burden settings, in line with WHO recommendations.1 Yet mortality remains unacceptably high despite these interventions.2 The EMPIRICAL trial by Cinta Moraleda and colleagues challenges another long-standing assumption; perhaps one important pathogen has been hiding in plain sight.